1
|
Khalilzad Sharghi V, Maltbie EA, Pan WJ, Keilholz SD, Gopinath KS. Selective blockade of rat brain T-type calcium channels provides insights on neurophysiological basis of arousal dependent resting state functional magnetic resonance imaging signals. Front Neurosci 2022; 16:909999. [PMID: 36003960 PMCID: PMC9393715 DOI: 10.3389/fnins.2022.909999] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/31/2022] [Accepted: 07/19/2022] [Indexed: 12/04/2022] Open
Abstract
A number of studies point to slow (0.1–2 Hz) brain rhythms as the basis for the resting-state functional magnetic resonance imaging (rsfMRI) signal. Slow waves exist in the absence of stimulation, propagate across the cortex, and are strongly modulated by vigilance similar to large portions of the rsfMRI signal. However, it is not clear if slow rhythms serve as the basis of all neural activity reflected in rsfMRI signals, or just the vigilance-dependent components. The rsfMRI data exhibit quasi-periodic patterns (QPPs) that appear to increase in strength with decreasing vigilance and propagate across the brain similar to slow rhythms. These QPPs can complicate the estimation of functional connectivity (FC) via rsfMRI, either by existing as unmodeled signal or by inducing additional wide-spread correlation between voxel-time courses of functionally connected brain regions. In this study, we examined the relationship between cortical slow rhythms and the rsfMRI signal, using a well-established pharmacological model of slow wave suppression. Suppression of cortical slow rhythms led to significant reduction in the amplitude of QPPs but increased rsfMRI measures of intrinsic FC in rats. The results suggest that cortical slow rhythms serve as the basis of only the vigilance-dependent components (e.g., QPPs) of rsfMRI signals. Further attenuation of these non-specific signals enhances delineation of brain functional networks.
Collapse
Affiliation(s)
- Vahid Khalilzad Sharghi
- Department of Biomedical Engineering, Emory University-Georgia Tech, Atlanta, GA, United States
| | - Eric A. Maltbie
- Department of Biomedical Engineering, Emory University-Georgia Tech, Atlanta, GA, United States
| | - Wen-Ju Pan
- Department of Biomedical Engineering, Emory University-Georgia Tech, Atlanta, GA, United States
| | - Shella D. Keilholz
- Department of Biomedical Engineering, Emory University-Georgia Tech, Atlanta, GA, United States
| | - Kaundinya S. Gopinath
- Department of Radiology & Imaging Sciences, Emory University, Atlanta, GA, United States
- *Correspondence: Kaundinya S. Gopinath,
| |
Collapse
|
2
|
Drucker JH, Epstein CM, McGregor KM, Hortman K, Gopinath KS, Crosson B. Reduced Interference and Serial Dependency Effects for Naming in Older but Not Younger Adults after 1 Hz rTMS of Right Pars Triangularis. Neurobiol Lang (Camb) 2022; 3:256-271. [PMID: 37215557 PMCID: PMC10158568 DOI: 10.1162/nol_a_00063] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Figures] [Subscribe] [Scholar Register] [Received: 12/15/2020] [Accepted: 11/25/2021] [Indexed: 05/24/2023]
Abstract
1 Hz repetitive transcranial magnetic stimulation (rTMS) was used to decrease excitability of right pars triangularis (R PTr) to determine whether increased R PTr activity during picture naming in older adults hampers word finding. We hypothesized that decreasing R PTr excitability would reduce interference with word finding, facilitating faster picture naming. 15 older and 16 younger adults received two rTMS sessions. In one, speech onset latencies for picture naming were measured after both sham and active R PTr stimulation. In the other session, sham and active stimulation of a control region, right pars opercularis (R POp), were administered before picture naming. Order of active vs. sham stimulation within session was counterbalanced. Younger adults showed no significant effects of stimulation. In older adults, a trend indicated that participants named pictures more quickly after active than sham R PTr stimulation. However, older adults also showed longer responses during R PTr than R POp sham stimulation. When order of active vs. sham stimulation was modeled, older adults receiving active stimulation first had significantly faster responding after active than sham R PTr stimulation and significantly faster responding after R PTr than R POp stimulation, consistent with experimental hypotheses. However, older adults receiving sham stimulation first showed no significant differences between conditions. Findings are best understood, based on previous studies, when the interaction between the excitatory effects of picture naming and the inhibitory effects of 1 Hz rTMS on R PTr is considered. Implications regarding right frontal activity in older adults and for design of future experiments are discussed.
Collapse
Affiliation(s)
- Jonathan H. Drucker
- VA Rehabilitation Research & Development Center for Visual and Neurocognitive Rehabilitation, Decatur, GA, USA
- Department of Neurology, Emory University, Atlanta, GA, USA
- Aptima, Inc., Woburn, MA, USA
| | | | - Keith M. McGregor
- VA Rehabilitation Research & Development Center for Visual and Neurocognitive Rehabilitation, Decatur, GA, USA
- Department of Neurology, Emory University, Atlanta, GA, USA
| | - Kyle Hortman
- VA Rehabilitation Research & Development Center for Visual and Neurocognitive Rehabilitation, Decatur, GA, USA
| | | | - Bruce Crosson
- VA Rehabilitation Research & Development Center for Visual and Neurocognitive Rehabilitation, Decatur, GA, USA
- Department of Neurology, Emory University, Atlanta, GA, USA
- Department of Psychology, Georgia State University, Atlanta, GA, USA
| |
Collapse
|
3
|
Gopinath KS. Have We Made the Progress? Indian J Surg Oncol 2021; 12:453. [PMID: 34658569 DOI: 10.1007/s13193-021-01435-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
Affiliation(s)
- K S Gopinath
- Division of Surgical Oncology, HCG Cancer Hospital, Health Care Global Enterprises, Bangalore, 560027 India
| |
Collapse
|
4
|
Affiliation(s)
- Arvind Krishnamurthy
- Surgical Oncology, Cancer Institute (WIA), 38, Sardar Patel Rd, Adyar, Chennai, 600036 India
| | - K S Gopinath
- HCG Hospital, Bengaluru, India.,Sri Devaraj Urs Medical College, Kolar, India
| |
Collapse
|
5
|
Mirza AA, Srinivas KG, Amarendra S, Swamy S, Krishna A, Gopinath KS. Versatility of Rectus Abdominis Myocutaneous Flap in Primary Reconstruction of Defects in Surgical Oncology. Indian J Surg Oncol 2020; 11:740-745. [PMID: 33281413 DOI: 10.1007/s13193-020-01213-4] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/25/2020] [Accepted: 09/08/2020] [Indexed: 10/23/2022] Open
Abstract
With the advent of microvascular surgery, the choice of reconstruction following resection of the primary has an important bearing on the final functional and cosmetic outcome in surgical oncology. The vertical rectus abdominis myocutaneous (VRAM) flap is arguably the most widely used and versatile flap in reconstructive surgery. All patients undergoing a VRAM flap reconstruction following resection of their tumor in the Surgical Oncology Department of a tertiary cancer center from 2012 to 2019 were included in the study. Defects ranged from the breast (40), head and neck (10), groin (3), and perineum (5). The primary outcome measure was incidence of complete and partial flap necrosis, while incidence of hematoma, seroma, incisional hernia, wound dehiscence, and infection were secondary outcomes measured. The patients were followed up for a minimum period of 1 year. The incidence of complete flap necrosis was 5.1% (3) and partial loss 12% (7). Incidence of minor complications such as seroma was 13.7% (8), hematoma 6.8% (4), wound dehiscence 10.3% (6), and wound infection 5.1% (3). Incisional hernia and donor site wound-related complications were not seen in any. On binary regression analysis, the presence of diabetes mellitus, smoking, and the use of adjuvant treatment were associated significantly with increased odds of flap loss. This study demonstrates the versatility and reliability of the VRAM flap in primary reconstruction of defects in surgical oncology. Optimization of risk factors such as diabetes, smoking, and weight gain can reduce flap loss and improve outcomes.
Collapse
Affiliation(s)
- Abid Ali Mirza
- Omega Sushrutha Cancer Hospital, No. 8-5-11, Housing Board Colony, Opp. Old Power House, Karimnagar, Telangana State 500001 India
| | | | - Shankarappa Amarendra
- HCG-Bangalore Institute of Oncology, 44/45-2, 2nd Cross, RRMR extension, Bangalore, Karnataka 560027 India
| | - Shivananda Swamy
- HCG-Bangalore Institute of Oncology, 44/45-2, 2nd Cross, RRMR extension, Bangalore, Karnataka 560027 India
| | - Anand Krishna
- HCG-Bangalore Institute of Oncology, 44/45-2, 2nd Cross, RRMR extension, Bangalore, Karnataka 560027 India
| | - K S Gopinath
- HCG-Bangalore Institute of Oncology, 44/45-2, 2nd Cross, RRMR extension, Bangalore, Karnataka 560027 India
| |
Collapse
|
6
|
Maltbie EA, Gopinath KS, Howell LL. Effects of ketamine treatment on cocaine-induced reinstatement and disruption of functional connectivity in unanesthetized rhesus monkeys. Psychopharmacology (Berl) 2019; 236:2105-2118. [PMID: 30879118 DOI: 10.1007/s00213-019-05204-4] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/31/2018] [Accepted: 02/18/2019] [Indexed: 01/28/2023]
Abstract
RATIONALE Substance use disorders are characterized by a loss of executive control over reward-based decision-making, and disruption of fronto-striatal connectivity has been implicated in this process. Sub-anesthetic ketamine has recently been shown to bolster fronto-striatal connectivity in drug-naïve subjects. OBJECTIVES The influence of ketamine treatment was examined on the disruptive effects of cocaine on functional connectivity (FC) and on cocaine-seeking behavior in female rhesus monkeys. METHODS Three female rhesus were trained for unanesthetized MRI scanning. Each received three drug-naïve/abstinent pharmacological MRI scans with acute injections of saline, cocaine (0.3 mg/kg i.v.), and cocaine (0.3 mg/kg i.v.) 48-h after a ketamine treatment (low dose = 0.345 mg/kg bolus + 0.256 mg/kg/h for 1 h; i.v.), and a fourth scan with saline injection following 2 months of daily cocaine self-administration. A separate cohort of five rhesus (4 female), all with extensive histories of cocaine exposure, underwent reinstatement testing 48 h after ketamine (or vehicle) treatment. Two sub-anesthetic doses were tested: low dose and high dose = 0.69 mg/kg + 0.512 mg/kg/h for 1 h. RESULTS Ketamine treatment attenuated the effects of cocaine on both global and fronto-striatal FC in drug-naïve/abstinent subjects. Two months of daily cocaine self-administration led to prolonged disruption of both global and fronto-striatal FC. Cocaine-seeking behavior during reinstatement was reduced following ketamine treatment at the low dose, but not high dose. CONCLUSION These findings illustrate the disruptive effects of cocaine on functional connectivity and provide evidence for the potential efficacy of ketamine as a treatment for stimulant use disorder.
Collapse
Affiliation(s)
- Eric A Maltbie
- Yerkes National Primate Research Center, Emory University, 954 Gatewood Rd NE, Atlanta, GA, 30329, USA
| | - Kaundinya S Gopinath
- Yerkes National Primate Research Center, Emory University, 954 Gatewood Rd NE, Atlanta, GA, 30329, USA.,Department of Radiology and Imaging Sciences, Emory University, Atlanta, GA, 30329, USA
| | - Leonard L Howell
- Yerkes National Primate Research Center, Emory University, 954 Gatewood Rd NE, Atlanta, GA, 30329, USA. .,Department of Psychiatry and Behavioral Sciences, Emory University, Atlanta, GA, 30329, USA.
| |
Collapse
|
7
|
Gopinath KS, Sakoglu U, Crosson BA, Haley RW. Exploring brain mechanisms underlying Gulf War Illness with group ICA based analysis of fMRI resting state networks. Neurosci Lett 2019; 701:136-141. [DOI: 10.1016/j.neulet.2019.02.041] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2018] [Revised: 02/16/2019] [Accepted: 02/26/2019] [Indexed: 11/24/2022]
|
8
|
Gopinath KS. Correction to: Desk of the Editor Vol. 9 Issue 4. Indian J Surg Oncol 2019; 10:414. [PMID: 31168276 DOI: 10.1007/s13193-019-00878-w] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022] Open
Abstract
[This corrects the article DOI: 10.1007/s13193-018-0819-6.].
Collapse
Affiliation(s)
- K S Gopinath
- Bangalore Institute of Oncology, Bengaluru, India
| |
Collapse
|
9
|
Smalley M, Shanthappa BU, Gertje H, Lawson M, Ulaganathan B, Thayakumar A, Maciejko L, Radhakrishnan P, Biswas M, Thiyagarajan S, Majumder B, Gopinath KS, K GB, Goldman A. Abstract P5-11-04: Therapy-induced priming of natural killer cells predicts patient-specific tumor rejection in multiple breast cancer indications. Cancer Res 2018. [DOI: 10.1158/1538-7445.sabcs17-p5-11-04] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Background: Predicting patient-specific clinical response to anticancer therapy is the holy grail of treatment-selection. It is now clear that response or resistance to therapy depends on the heterogeneous tumor microenvironment, which is comprised of malignant cells, normal stroma, soluble ligands, and tumor-immune contexture; attributes that are unique to each individual patient. This is particularly true for emerging anticancer drugs, such as immune checkpoint inhibitors, which recalibrate the body's own immune defense largely by modulating exhaustion of cytotoxic lymphocytes including T cells and natural killer (NK) cells. However, clinical response to therapy varies enormously. There is a critical gap in our understanding for the mechanisms that drive response or resistance to conventional drugs and immunotherapies at the individual patient level.
Methods: Here, we used a fully patient-autologous, clinically-validated ex-vivo tumor model that recreates and preserves the native, patient tumor microenvironment (CANscriptTM), which incorporates an algorithm-driven method to predict clinical response to therapy (M-Score). Utilizing tissue from patients diagnosed with luminal, HER2 positive, and triple-negative (ER- PR- HER2-) breast cancers (N=10), we studied phenotypic alterations to the tumor-immune contexture under pressure of conventional standard-of-care regimens and immunotherapies including immune-checkpoint inhibitors, ex-vivo. To do this, we used a comprehensive panel of immunological assays to evaluate changes in cytotoxic lymphocytes by flow cytometry and multiplex immunohistochemistry (i.e. CD56, MHC class 1A/B, NKG2D/C, CD8, CD3, PD-1, CTLA-4, TIM-3, LAG-3, 4-1BB, granzyme A/B). In addition, we used multiplex cytokine analysis to study the soluble components of the tumor microenvironment.
Results: We identified that tumor response, predicted by M-Score, correlates to increased infiltration of NK cells, which associated a pro-inflammatory cytokine signature from the tumor microenvironment. Interestingly, these evidences were concordant with induction of the tumor-expressing biomarker MICA/B, which is known to attract and recruit active NK cells. Furthermore, we determined that therapy-induced expression of protein biomarkers associated with NK cell exhaustion inversely correlated to the expression of cytotoxic granzyme B in the tumor microenvironment.
Conclusions: Taken together, these data demonstrate an integral role that NK cells contribute to the antitumor effect of therapy including conventional and immuno-modulatory drugs. It further demonstrates how a novel ex-vivo platform can be harnessed to study the mechanisms of response and resistance, which couldn't otherwise be known in a drug naïve state. Such an advance in our preclinical methods to study anticancer drugs at the individual patient level can help guide treatment decisions for clinicians while simultaneously functioning as a platform to study clinical efficacy of novel and emerging agents.
Citation Format: Smalley M, Shanthappa BU, Gertje H, Lawson M, Ulaganathan B, Thayakumar A, Maciejko L, Radhakrishnan P, Biswas M, Thiyagarajan S, Majumder B, Gopinath KS, K GB, Goldman A. Therapy-induced priming of natural killer cells predicts patient-specific tumor rejection in multiple breast cancer indications [abstract]. In: Proceedings of the 2017 San Antonio Breast Cancer Symposium; 2017 Dec 5-9; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2018;78(4 Suppl):Abstract nr P5-11-04.
Collapse
Affiliation(s)
- M Smalley
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - BU Shanthappa
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - H Gertje
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - M Lawson
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - B Ulaganathan
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - A Thayakumar
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - L Maciejko
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - P Radhakrishnan
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - M Biswas
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - S Thiyagarajan
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - B Majumder
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - KS Gopinath
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - GB K
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| | - A Goldman
- Integrative Immuno-Oncology Center Mitra RxDx Inc., Woburn, MA; Mitra RxDx, Bangalore, Karnataka, India; Bangalore Institute of Oncology, Bangalore, Karnataka, India; Kidwai Memorial Institute of Oncology, Bangalore, Karnataka, India
| |
Collapse
|
10
|
Bhatt A, Mehta S, Pande P, Rajan F, Rangole A, Saklani A, Sethna K, Singh S, Zaveri S, Gopinath KS. Setting up of the Indian HIPEC Registry: A Registry for Indian Patients with Peritoneal Surface Malignancies. Indian J Surg Oncol 2017; 8:527-532. [PMID: 29203985 DOI: 10.1007/s13193-017-0693-7] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/16/2017] [Accepted: 08/07/2017] [Indexed: 11/25/2022] Open
Abstract
There are various registries for patients with peritoneal metastases (PM) that aid pooling of data and generate evidence that dictates current clinical practice. This manuscript describes the setting up of the Indian HIPEC registry that was set up with a similar goal by a group of Indian surgeons. This is a registry for patients with PM treated with CRS and HIPEC in India. It also acts as a database for storing treatment-related information. Patients with PM from colorectal ovarian, gastric, appendiceal tumors, and other rare peritoneal tumors/metastases from rare tumors are enrolled in the registry. A coordinator updates the disease status of patients on a yearly basis. A private organization maintains the database. A non-disclosure agreement is signed between the company and each surgeon contributing to the registry to maintain confidentiality. For enrolling patients, securing institutional permission depends on the requirement of each institute; patient consent is mandatory. Data entry can be prospective or retrospective. To propose and conduct a study, the approval of a scientific committee linked to the registry is required. The Indian HIPEC registry is a practical database for Indian surgeons. There is no regulatory body that mandates collection and publication of scientific data in India. The onus is on each surgeon to capture valuable information pertaining to these common and rare diseases that could contribute to the existing scientific knowledge and guide the treatment of these patients in the future. The next challenge will be to enter data into the registry.
Collapse
Affiliation(s)
- Aditi Bhatt
- Department of Surgical Oncology, Fortis Hospital, 154/9 Bannerghatta road, Opposite IIM-B, Bangalore, 560076 India
| | | | | | | | | | | | | | | | | | | |
Collapse
|
11
|
Prabhu JS, Korlimarla A, Anupama CE, Alexander A, Raghavan R, Kaul R, Desai K, Rajarajan S, Manjunath S, Correa M, Raman R, Kalamdani A, Prasad M, Patil S, Gopinath KS, Srinath BS, Sridhar TS. Dissecting the Biological Heterogeneity within Hormone Receptor Positive HER2 Negative Breast Cancer by Gene Expression Markers Identifies Indolent Tumors within Late Stage Disease. Transl Oncol 2017; 10:699-706. [PMID: 28704710 PMCID: PMC5506875 DOI: 10.1016/j.tranon.2017.04.011] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/07/2016] [Accepted: 04/27/2017] [Indexed: 12/20/2022] Open
Abstract
Hormone receptor positive (HR+) breast cancers are a heterogeneous class with differential prognosis. Although more than half of Indian women present with advanced disease, many such patients do well. We have attempted identification of biologically indolent tumors within HR+HER2- tumors based on gene expression using histological grade as a guide to tumor aggression. 144 HR+HER2- tumors were divided into subclasses based on scores derived by using transcript levels of multiple genes representing survival, proliferation, and apoptotic pathways and compared to classification by Ki-67 labeling index (LI). Clinical characters and disease free survival were compared between the subclasses. The findings were independently validated in the METABRIC data set. Using the previously established estrogen receptor (ER) down stream activity equation, 20% of the tumors with greater than 10% HR positivity by immunohistochemistry (IHC) were still found to have inadequate ER function. A tumor aggression probability score was used to segregate the remainder of tumors into indolent (22%) and aggressive (58%) classes. Significant difference in disease specific survival was seen between the groups (P = .02). Aggression probability based subclassification had a higher hazard ratio and also independent prognostic value (P < .05). Independent validation of the gene panel in the METABRIC data set showed all 3 classes; indolent (24%), aggressive (68%), and insufficient ER signaling (7%) with differential survival (P = .01). In agreement with other recent reports, biologically indolent tumors can be identified with small sets of gene panels and these tumors exist in a population with predominantly late stage disease.
Collapse
Affiliation(s)
- Jyothi S Prabhu
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India.
| | - Aruna Korlimarla
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - C E Anupama
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Annie Alexander
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Rohini Raghavan
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Roma Kaul
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Krisha Desai
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Savitha Rajarajan
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Suraj Manjunath
- Department of Surgical Oncology, Department of Pathology, St. John's Medical College Hospital, Bangalore, India
| | - Marjorrie Correa
- Department of Surgical Oncology, Department of Pathology, St. John's Medical College Hospital, Bangalore, India
| | - R Raman
- Shankara Cancer Hospital and Research Centre, Bangalore, India
| | | | - Msn Prasad
- Shankara Cancer Hospital and Research Centre, Bangalore, India
| | - Shekar Patil
- Shankara Cancer Hospital and Research Centre, Bangalore, India
| | | | - B S Srinath
- Shankara Cancer Hospital and Research Centre, Bangalore, India
| | - T S Sridhar
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| |
Collapse
|
12
|
Vadiraja HS, Rao RM, Nagarathna R, Nagendra HR, Patil S, Diwakar RB, Shashidhara HP, Gopinath KS, Ajaikumar BS. Effects of Yoga in Managing Fatigue in Breast Cancer Patients: A Randomized Controlled Trial. Indian J Palliat Care 2017; 23:247-252. [PMID: 28827926 PMCID: PMC5545948 DOI: 10.4103/ijpc.ijpc_95_17] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
Background: Cancer-related fatigue is widely prevalent in cancer patients and affects quality of life in advanced cancer patients. Fatigue is caused due to both psychologic distress and physiological sequel following cancer progression and its treatment. In this study, we evaluate the effects of yogic intervention in managing fatigue in metastatic breast cancer patients. Methods: Ninety-one patients with metastatic breast cancer were randomized to receive integrated yoga program (n = 46) or supportive therapy and education (n = 45) over a 3-month period. Assessments such as perceived stress, fatigue symptom inventory, diurnal salivary cortisol, and natural killer cell counts were carried out before and after intervention. Analysis was done using an intention-to-treat approach. Postmeasures for the above outcomes were assessed using ANCOVA with respective baseline measure as a covariate. Results: The results suggest that yoga reduces perceived stress (P = 0.001), fatigue frequency (P < 0.001), fatigue severity (P < 0.001), interference (P < 0.001), and diurnal variation (P < 0.001) when compared to supportive therapy. There was a positive correlation of change in fatigue severity with 9 a.m. salivary cortisol levels. Conclusion: The results suggest that yoga reduces fatigue in advanced breast cancer patients.
Collapse
Affiliation(s)
- H S Vadiraja
- Department of Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India
| | - Raghavendra Mohan Rao
- Department of Complementary Alternative Medicine, Health Care Global Enterprises Ltd., Bengaluru, Karnataka, India
| | - R Nagarathna
- Department of Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India
| | - H R Nagendra
- Department of Research and Development, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India
| | - Shekhar Patil
- Department of Medical Oncology, HCG Bangalore Institute of Oncology Specialty Center, Bengaluru, Karnataka, India
| | - Ravi B Diwakar
- Department of Medical Oncology, HCG Bangalore Institute of Oncology Specialty Center, Bengaluru, Karnataka, India
| | - H P Shashidhara
- Department of Medical Oncology, HCG Bangalore Institute of Oncology Specialty Center, Bengaluru, Karnataka, India
| | - K S Gopinath
- Department of Surgical Oncology, HCG Bangalore Institute of Oncology, Bengaluru, Karnataka, India
| | - B S Ajaikumar
- Department of Radiation Oncology, HCG Bangalore Institute of Oncology, Bengaluru, Karnataka, India
| |
Collapse
|
13
|
Rao RM, Vadiraja HS, Nagaratna R, Gopinath KS, Patil S, Diwakar RB, Shahsidhara HP, Ajaikumar BS, Nagendra HR. Effect of Yoga on Sleep Quality and Neuroendocrine Immune Response in Metastatic Breast Cancer Patients. Indian J Palliat Care 2017; 23:253-260. [PMID: 28827927 PMCID: PMC5545949 DOI: 10.4103/ijpc.ijpc_102_17] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022] Open
Abstract
Background: Studies have shown that distress and accompanying neuroendocrine stress responses as important predictor of survival in advanced breast cancer patients. Some psychotherapeutic intervention studies have shown have modulation of neuroendocrine-immune responses in advanced breast cancer patients. In this study, we evaluate the effects of yoga on perceived stress, sleep, diurnal cortisol, and natural killer (NK) cell counts in patients with metastatic cancer. Methods: In this study, 91 patients with metastatic breast cancer who satisfied selection criteria and consented to participate were recruited and randomized to receive “integrated yoga based stress reduction program” (n = 45) or standard “education and supportive therapy sessions” (n = 46) over a 3 month period. Psychometric assessments for sleep quality were done before and after intervention. Blood draws for NK cell counts were collected before and after the intervention. Saliva samples were collected for three consecutive days before and after intervention. Data were analyzed using the analysis of covariance on postmeasures using respective baseline measure as a covariate. Results: There was a significant decrease in scales of symptom distress (P < 0.001), sleep parameters (P = 0.02), and improvement in quality of sleep (P = 0.001) and Insomnia Rating Scale sleep score (P = 0.001) following intervention. There was a decrease in morning waking cortisol in yoga group (P = 0.003) alone following intervention. There was a significant improvement in NK cell percent (P = 0.03) following intervention in yoga group compared to control group. Conclusion: The results suggest modulation of neuroendocrine responses and improvement in sleep in patients with advanced breast cancer following yoga intervention.
Collapse
Affiliation(s)
- Raghavendra Mohan Rao
- Department of Complementary and Alternative Medicine, Healthcare Global, Bengaluru, Karnataka, India
| | - H S Vadiraja
- Department of Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India
| | - R Nagaratna
- Department of Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India
| | - K S Gopinath
- Department of Surgical Oncology, HCG Bangalore Institute of Oncology Specialty Center, Bengaluru, Karnataka, India
| | - Shekhar Patil
- Department of Medical Oncology, HCG Bangalore Institute of Oncology Specialty Center, Bengaluru, Karnataka, India
| | - Ravi B Diwakar
- Department of Medical Oncology, HCG Bangalore Institute of Oncology Specialty Center, Bengaluru, Karnataka, India
| | - H P Shahsidhara
- Department of Medical Oncology, HCG Bangalore Institute of Oncology Specialty Center, Bengaluru, Karnataka, India
| | - B S Ajaikumar
- Department of Radiation Oncology, HCG Bangalore Institute of Oncology Specialty Center, Bengaluru, Karnataka, India
| | - H R Nagendra
- Department of Research and Development, Swami Vivekananda Yoga Anusandhana Samsthana, Bengaluru, Karnataka, India
| |
Collapse
|
14
|
Veldore VH, Rao MR, Prabhudesai SA, Tejaswi R, Kakara S, Pattanayak S, Krishnamoorthy N, Tejaswini BN, Hazarika D, Gangoli A, Rahman SM, Dixit J, Naik R, Diwakar RB, Satheesh CT, Shashidhara HP, Patil S, Gopinath KS, Kumar BS. Prevalence of KRAS mutations in metastatic colorectal cancer: A retrospective observational study from India. Indian J Cancer 2016; 51:531-7. [PMID: 26842186 DOI: 10.4103/0019-509x.175371] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
BACKGROUND One of the genetic alterations implicated in tumor progression in colorectal cancers (CRCs) are abnormalities in Kristen Rat Sarcoma (KRAS) gene. Evaluation of KRAS mutation status is an important prognostic factor and has predictive value in deciding first line therapy based on monoclonal antibodies such as Cetuximab and Panitumumab in metastatic CRCs. MATERIALS AND METHODS In this retrospective study, we analyzed 7 different somatic mutations in Exon 2 of KRAS gene in 299 unselected incidental CRC patients who visited the hospital for clinical management during the period 2009-2013. Most of the tumors were primarily originating from colon and rectum; nevertheless, there were a few from rectosigmoid, sigmoid, ceacum and anal canal in the study group. Genomic DNA extracted from paraffin embedded tumor tissues was screened for 7 point mutations located in Codons 12 and 13 of KRAS gene, using Scorpions amplified refractory mutation system real time polymerase chain reaction technology. Statistical analysis was performed to assess bivariate relationship between different variables that includes: mutation status, mutation type, tumor location, tumor morphology, age and sex. RESULTS Prevalence of mutation in Codons 12 and 13 was 42.8% in the study group. Well-differentiated tumors had significantly more mutation positivity than moderately and poorly differentiated tumors (P = 0.001). 92% of the mutations were from Codon 12 and 8% in Codon 13. Glycine to Arginine was relatively more common in rectosigmoid followed by ceacum, while Glycine to Alanine mutation was relatively more prevalent in sigmoid, followed by rectum and rectosigmoid. CONCLUSION The results suggest a prevalence of KRAS mutation at 42.8% in Indian population indicating that this testing is very crucial for targeted therapy management in metastatic CRC in India. Further analysis on mutation status of other homologues such as NRAS and downstream partner, v-raf murine sarcoma viral oncogene homolog B1, would add value to understanding the role of anti-epidermal growth factor receptor therapy in CRC management.
Collapse
Affiliation(s)
- V H Veldore
- Department of Molecular Pathology, Triesta Reference Laboratory, Triesta Sciences, A unit of Healthcare Global Enterprises Ltd., Bengaluru, Karnataka, India
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
15
|
Desai K, Nair MG, Prabhu JS, Vinod A, Korlimarla A, Rajarajan S, Aiyappa R, Kaluve RS, Alexander A, Hari PS, Mukherjee G, Kumar RV, Manjunath S, Correa M, Srinath BS, Patil S, Prasad MSN, Gopinath KS, Rao RN, Violette SM, Weinreb PH, Sridhar TS. High expression of integrin β6 in association with the Rho-Rac pathway identifies a poor prognostic subgroup within HER2 amplified breast cancers. Cancer Med 2016; 5:2000-11. [PMID: 27184932 PMCID: PMC4873607 DOI: 10.1002/cam4.756] [Citation(s) in RCA: 27] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/14/2016] [Revised: 01/29/2016] [Accepted: 04/05/2016] [Indexed: 12/31/2022] Open
Abstract
Integrin αvβ6 is involved in the transition from ductal carcinoma in situ (DCIS) to invasive ductal carcinoma (IDC) of the breast. In addition, integrin β6 (ITGB6) is of prognostic value in invasive breast cancers, particularly in HER2+ subtype. However, pathways mediating the activity of integrin αvβ6 in clinical progression of invasive breast cancers need further elucidation. We have examined human breast cancer specimens (N = 460) for the expression of integrin β6 (ITGB6) mRNA by qPCR. In addition, we have examined a subset (N = 147) for the expression of αvβ6 integrin by immunohistochemistry (IHC). The expression levels of members of Rho–Rac pathway including downstream genes (ACTR2,ACTR3) and effector proteinases (MMP9,MMP15) were estimated by qPCR in the HER2+ subset (N = 59). There is a significant increase in the mean expression of ITGB6 in HER2+ tumors compared to HR+HER2‐ and triple negative (TNBC) subtypes (P = 0.00). HER2+ tumors with the highest levels (top quartile) of ITGB6 have significantly elevated levels of all the genes of the Rho–Rac pathway (P‐values from 0.01 to 0.0001). Patients in this group have a significantly shorter disease‐free survival compared to the group with lower ITGB6 levels (HR = 2.9 (0.9–8.9), P = 0.05). The mean level of ITGB6 expression is increased further in lymph node‐positive tumors. The increased regional and distant metastasis observed in HER2+ tumors with high levels of ITGB6 might be mediated by the canonical Rho–Rac pathway through increased expression of MMP9 and MMP15.
Collapse
Affiliation(s)
- Krisha Desai
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Madhumathy G Nair
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Jyothi S Prabhu
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Anupama Vinod
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Aruna Korlimarla
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Savitha Rajarajan
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Radhika Aiyappa
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Rohini S Kaluve
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - Annie Alexander
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | - P S Hari
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| | | | - Rekha V Kumar
- Kidwai Medical Institute of Oncology, Bangalore, India
| | | | | | - B S Srinath
- Shankara Cancer Hospital and Research Centre, Bangalore, India
| | - Shekhar Patil
- Shankara Cancer Hospital and Research Centre, Bangalore, India
| | - M S N Prasad
- Shankara Cancer Hospital and Research Centre, Bangalore, India
| | | | - Raman N Rao
- Rangadore Memorial Hospital, Bangalore, India
| | | | | | - T S Sridhar
- Division of Molecular Medicine, St. John's Research Institute, Bangalore, India
| |
Collapse
|
16
|
Bhatt A, Mittal S, Gopinath KS. Safety considerations for Health care Workers involved in Cytoreductive Surgery and Perioperative chemotherapy. Indian J Surg Oncol 2016; 7:249-57. [PMID: 27065717 DOI: 10.1007/s13193-016-0503-7] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/17/2016] [Accepted: 01/28/2016] [Indexed: 12/29/2022] Open
Abstract
The combined modality treatment of cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) has gained worldwide acceptance for management of selected patients with peritoneal metastases from various cancers. Cytoreductive surgery is performed with the goal of removing all macroscopic disease and is coupled with perioperative chemotherapy (POC) in the form of HIPEC with or without EPIC (early postoperative intraperitoneal chemotherapy) to deal with the microscopic residual disease. These treatments entail the use of cytotoxic drugs in the operation theatre or in the intensive care unit where they are not commonly used and put the healthcare workers participating in the treatment at risk of exposure. CRS is performed with high voltage electrocautery generating a large amount of surgical smoke which is inhaled by the involved personnel and has potential health hazards. This article outlines the safety measures to be taken while performing CRS and POC.
Collapse
Affiliation(s)
- Aditi Bhatt
- Department of Surgical Oncology, Fortis Hospital, 154/9 Bannerghatta road, Opposite IIM-Bangalore, Bangalore, -560076 India
| | - Sourabh Mittal
- Department of Surgical Oncology, Fortis Hospital, 154/9 Bannerghatta road, Opposite IIM-Bangalore, Bangalore, -560076 India
| | - K S Gopinath
- Department of Surgical Oncology, HCG Bangalore Institute of Oncology, Bangalore, India
| |
Collapse
|
17
|
Rao RM, Raghuram N, Nagendra HR, Usharani MR, Gopinath KS, Diwakar RB, Patil S, Bilimagga RS, Rao N. Effects of an integrated Yoga Program on Self-reported Depression Scores in Breast Cancer Patients Undergoing Conventional Treatment: A Randomized Controlled Trial. Indian J Palliat Care 2015; 21:174-81. [PMID: 26009671 PMCID: PMC4441179 DOI: 10.4103/0973-1075.156486] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
Abstract
Aim: To compare the effects of yoga program with supportive therapy on self-reported symptoms of depression in breast cancer patients undergoing conventional treatment. Patients and Methods: Ninety-eight breast cancer patients with stage II and III disease from a cancer center were randomly assigned to receive yoga (n = 45) and supportive therapy (n = 53) over a 24-week period during which they underwent surgery followed by adjuvant radiotherapy (RT) or chemotherapy (CT) or both. The study stoppage criteria was progressive disease rendering the patient bedridden or any physical musculoskeletal injury resulting from intervention or less than 60% attendance to yoga intervention. Subjects underwent yoga intervention for 60 min daily with control group undergoing supportive therapy during their hospital visits. Beck's Depression Inventory (BDI) and symptom checklist were assessed at baseline, after surgery, before, during, and after RT and six cycles of CT. We used analysis of covariance (intent-to-treat) to study the effects of intervention on depression scores and Pearson correlation analyses to evaluate the bivariate relationships. Results: A total of 69 participants contributed data to the current analysis (yoga, n = 33, and controls, n = 36). There was 29% attrition in this study. The results suggest an overall decrease in self-reported depression with time in both the groups. There was a significant decrease in depression scores in the yoga group as compared to controls following surgery, RT, and CT (P < 0.01). There was a positive correlation (P < 0.001) between depression scores with symptom severity and distress during surgery, RT, and CT. Conclusion: The results suggest possible antidepressant effects with yoga intervention in breast cancer patients undergoing conventional treatment.
Collapse
Affiliation(s)
- Raghavendra Mohan Rao
- Department of Complementary and Alternative Medicine, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| | - Nagarathna Raghuram
- Swami Vivekananda Yoga Anusandhana Samsthana, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| | - H R Nagendra
- Swami Vivekananda Yoga Anusandhana Samsthana, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| | - M R Usharani
- Department of Complementary and Alternative Medicine, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| | - K S Gopinath
- Department of Surgical Oncology, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| | - Ravi B Diwakar
- Department of Medical Oncology, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| | - Shekar Patil
- Department of Medical Oncology, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| | - Ramesh S Bilimagga
- Department of Radiation Oncology, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| | - Nalini Rao
- Department of Radiation Oncology, Healthcare Global Enterprises Ltd, Bangalore, Karnataka, India
| |
Collapse
|
18
|
Gopinath KS. From the Desk of the Editor: Season's greeting and Happy New year 2014. Indian J Surg Oncol 2015; 11:273. [PMID: 33364717 DOI: 10.1007/s13193-014-0363-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Affiliation(s)
- K S Gopinath
- HCG - Bangalore Institiute of Oncology, Bangalore & Prof. of Surgery & Oncology, Sri Devaraj Urs Medical College, Kolar. No. 20, Srinivasa Behind Balaji Kalyana Mantapam, BSK III Stage, Bangalore, 560085 India
| |
Collapse
|
19
|
Gopinath KS. From the desk of the editor. Indian J Surg Oncol 2014; 5:167. [PMID: 25419057 DOI: 10.1007/s13193-014-0355-y] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
Affiliation(s)
- K S Gopinath
- HCG - Bangalore Institiute of Oncology, Bangalore & Prof. of Surgery & Oncology, Sri Devaraj Urs Medical College, Kolar. No. 20, Srinivasa Behind Balaji Kalyana Mantapam, BSK III Stage, Bangalore, 560085 India
| |
Collapse
|
20
|
Kattepur AK, Patil DB, Krishnamoorthy N, Srinivas KG, Swamy S, Amarendra S, Gopinath KS. Isolated nasopharyngeal metastasis from hepatocellular carcinoma. Int J Surg Case Rep 2014; 5:115-7. [PMID: 24509427 DOI: 10.1016/j.ijscr.2013.12.009] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2013] [Revised: 11/16/2013] [Accepted: 12/12/2013] [Indexed: 01/09/2023] Open
Abstract
INTRODUCTION Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide, the incidence of which parallels that of areas with high prevalence of chronic hepatitis. HCC commonly metastasizes to the lungs, lymph nodes, adrenals and bones with the overall prognosis of metastatic HCC being dismal. PRESENTATION OF CASE We herein with present a case of a 70-year-old male who was referred to our institution with history of nasal obstruction and nasal bleeding which on further evaluation was diagnosed to have an isolated metastasis to nasopharynx from liver primary. DISCUSSION Extrahepatic metastasis in HCC occurs in about 30-50% of patients, the commonest site being the lung. Rare sites of extrahepatic metastasis from HCC to the ovaries, kidneys, skeletal and cardiac musculature and brain have been reported. Unusual sites of metastasis in the head and neck area like the mandible have also been documented. With the changing trends in the treatment modalities, these patients are often treated using target therapy. CONCLUSION This article presents an unusual isolated metastasis to nasopharynx from HCC in the absence of disseminated disease. This case report illustrates the distinctive pathological features of metastatic HCC.
Collapse
Affiliation(s)
- Abhay K Kattepur
- Department of Surgical Oncology and Onco-pathology, HCG-Bangalore Institute of Oncology, 44-45/2, 2nd Cross, RRMR Extension, Bangalore 560027, India.
| | - Darshan B Patil
- Department of Surgical Oncology and Onco-pathology, HCG-Bangalore Institute of Oncology, 44-45/2, 2nd Cross, RRMR Extension, Bangalore 560027, India.
| | - Naveen Krishnamoorthy
- Department of Surgical Oncology and Onco-pathology, HCG-Bangalore Institute of Oncology, 44-45/2, 2nd Cross, RRMR Extension, Bangalore 560027, India.
| | - K G Srinivas
- Department of Surgical Oncology and Onco-pathology, HCG-Bangalore Institute of Oncology, 44-45/2, 2nd Cross, RRMR Extension, Bangalore 560027, India.
| | - Shivananda Swamy
- Department of Surgical Oncology and Onco-pathology, HCG-Bangalore Institute of Oncology, 44-45/2, 2nd Cross, RRMR Extension, Bangalore 560027, India.
| | - S Amarendra
- Department of Surgical Oncology and Onco-pathology, HCG-Bangalore Institute of Oncology, 44-45/2, 2nd Cross, RRMR Extension, Bangalore 560027, India.
| | - K S Gopinath
- Department of Surgical Oncology and Onco-pathology, HCG-Bangalore Institute of Oncology, 44-45/2, 2nd Cross, RRMR Extension, Bangalore 560027, India.
| |
Collapse
|
21
|
Kaul R, Prabhu JS, Swaminath S, Korlimarla A, Correa M, Prasad MSN, Manjunath S, Gopinath KS, Swami S, Shastry SB, Sridhar TS. Abstract P4-07-09: An approach to the identification of tumors driven by HER2 using the integrated activity of oncomiR miR-21 along with HER2 enriched genes. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p4-07-09] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction: The initial identification of HER2 as a driver in a subset of breast cancers was at the level of DNA (amplification), and subsequently noted at the level of transcripts and protein as well. However, the clinical selection of patients for treatment with Trastuzumab, has been through either IHC (protein) or FISH (DNA amplification) and not through transcript abundance. Interestingly, in most studies that have estimated transcript abundance in primary tumors, the proportion of patients that demonstrate increased transcript levels (termed HER2 Enriched) have tended to be slightly larger than the clinical HER2+ category.
A more clinically useful measure might be proof of HER2 downstream activity that might help separate tumors being driven significantly by HER2 from ones where its role is supportive. One of the many consequences of HER2 over-expression is activation of the oncomiR, miR-21 via the MAPK pathway. miR-21 in turn is known to epigenetically regulate multiple targets including the tumor suppressors PTEN and PDCD4. While these molecular mechanisms have been demonstrated convincingly in breast cancer cell lines, clinical studies of these alterations in large numbers are yet to be reported. In this study we have examined the relationship between clinical HER2 positivity and miR-21 levels in 124 surgically excised breast cancer specimens.
Methods: We selected 124 surgically excised specimens of primary breast cancers from our cohort that by HER2 immunohistochemistry (IHC) comprised 42 positive, 62 negative and 20 equivocal. Relative abundance of miR-21 was assessed using a TaqMan qRT-PCR, with normalization by RNU48. Relative transcript abundance of a set of 6 genes (HER2, GRB7, MLN64 and 3 reference genes) were evaluated by SYBR Green real time qPCR.
Results: The majority of tumors that were clinically HER2+ over expressed miR-21. A concordance with an AUC of 96% at 100% sensitivity and 85% specificity was noted. There is a highly significant differential expression of miR-21 between HER2 positive, negative and equivocal samples (P < 0.0001).
HER2 enriched score determined by using the expression levels of 3 genes (HER2, GRB7, MLN64) identified 35% (44/124) of the samples to be HER2 enriched. 72% of these (32/44) were also clinical HER2 positive by IHC. As expected, miR-21 was significantly over expressed in these tumors as well (P<0.0001).
To identify all samples which might show HER2 downstream activity, a logistic regression model was built using expression of miR-21, HER2, MLN64 and GRB7 as the determinants of HER2 status. The best fitting model classified 91% (38/42) of HER2 +, 95% (59/62) of the HER2 negative accurately with 94% specificity and an AUC of 0.96. The model helped identify 10% of clinical HER2 negative samples (6/20 equivocal & 3/62 HER-2 negative) to have a high probability of being HER2+.
Conclusion: Identification of HER2+ tumors with evidence of downstream activity may help identify patients with tumors being driven significantly by HER2 from ones where its role is supportive. The possibility of targeting miR-21 raises the tantalizing prospect of effecting change by altering the epigenetic regulation of multiple targets including tumor-suppressors.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P4-07-09.
Collapse
Affiliation(s)
- R Kaul
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - JS Prabhu
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - S Swaminath
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - A Korlimarla
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - M Correa
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - MSN Prasad
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - S Manjunath
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - KS Gopinath
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - S Swami
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - SB Shastry
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| | - TS Sridhar
- St. John's Research Institute, Bangalore, Karnataka, India; St. John's Medical College and Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Rangadore Memorial Hospital, Bangalore, Karnataka, India; Indian Institute of Science, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital and Research Centre, Bangalore, Karnataka, India
| |
Collapse
|
22
|
Raghavan R, Alexander A, Prabhu J, Korlimarla A, Correa M, Raman N, Prasad MSN, Manjunath S, Shivananda S, Gopinath KS, Srinath BS, Sridhar TS. Abstract P6-08-12: Gains in women’s education has not led to commensurate gains in seeking health-care early in breast cancer patients in urban India. Cancer Res 2013. [DOI: 10.1158/0008-5472.sabcs13-p6-08-12] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Introduction:
Breast cancer is the leading cancer diagnosed in urban Indian women. Historically the proportion of women presenting with advanced disease has been in excess of 50% at most regional cancer centres. The past 20 years has witnessed rapid economic growth and urbanization with significant gains in women's education and access to health. However, it is not clear if this has translated to earlier seeking of care in the educated.
The aim of this study was to examine if higher education (College) was a determinant in the time of seeking first medical consultation, and whether there were significant differences between women under the age of 40 versus women over 60 years old at the time of diagnosis.
Methods:
The data for analysis were obtained from a prospective longitudinal observational study conducted between 2008-2013 at a medical teaching hospital and a tertiary specialized cancer care centre. A total of 460 patients have been enrolled so far. All patients provided informed consent and the study has been reviewed and approved by the institutional ethics committees at these institutions. We have collected from the patients and their medical records information about their age at diagnosis, educational level, stage of disease, histopathology reports and clinical details.
Results:
Data from 194 patients have been used for the analysis. Patients were divided into one group of < = 40Y of age (Group I, N = 58) and the second of > = 60 years of age (Group II, N = 136). Mean age at presentation for the groups was 35 and 68 years respectively. As expected almost 1.5 times as many women under the age of 40 (36%) were college educated compared to the women over 60 (22%) (p = 0.05). The proportion of LABC in the two groups was not different with group I having 27% and group II 25%. The proportion of older women with LABC and a college degree was 20%. However, rather than the expected decrease in proportion of women with high education and LABC, 31% of young women with LABC had a college degree. LABC in the college educated was not different in the group I when compared to group II. (p = 0.39).
Conclusion:
The determinants of seeking health care are complex and influenced by a variety of factors including socio-economic status, access to health care, education, cultural beliefs, and personal preferences. While urban India's steady economic growth has been highlighted by the scholarly as well as the lay press, the data presented here suggest that there is not an automatic and linear transfer between education, economics and healthcare seeking behaviours. We suggest that while a lot of attention has been paid to awareness and screening, we may need to focus on local cultural factors, and perhaps provide support from female counsellors and care providers as critical components of attempting to bring our women to the hospital at the earliest.
Citation Information: Cancer Res 2013;73(24 Suppl): Abstract nr P6-08-12.
Collapse
Affiliation(s)
- R Raghavan
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - A Alexander
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - J Prabhu
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - A Korlimarla
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - M Correa
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - N Raman
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - MSN Prasad
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - S Manjunath
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - S Shivananda
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - KS Gopinath
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - BS Srinath
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| | - TS Sridhar
- St. John's Research Institution, Bangalore, Karnataka, India; St. John's Medical College & Hospital, Bangalore, Karnataka, India; St. John's Medical College, Bangalore, Karnataka, India; Sri Shankara Cancer Hospital & Research Centre, Bangalore, Karnataka, India; Sri Rangadore Memorial Hospital, Bangalore, Karnataka, India
| |
Collapse
|
23
|
Zaidel L, Allen G, Cullum CM, Briggs RW, Hynan LS, Weiner MF, McColl R, Gopinath KS, McDonald E, Rubin CD. Donepezil effects on hippocampal and prefrontal functional connectivity in Alzheimer's disease: preliminary report. J Alzheimers Dis 2013; 31 Suppl 3:S221-6. [PMID: 22886013 DOI: 10.3233/jad-2012-120709] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/17/2022]
Abstract
We used functional connectivity magnetic resonance imaging (fcMRI) to investigate changes in interhemispheric brain connectivity in 11 patients with mild Alzheimer's disease (AD) following eight weeks of treatment with the cholinesterase inhibitor donepezil. We examined functional connectivity between four homologous temporal, frontal, and occipital regions. These regions were selected to represent sites of AD neuropathology, sites of donepezil-related brain activation change in prior studies, and sites that are minimally affected by the pathologic changes of AD. Based on previous findings of selective, localized frontal responses to donepezil, we predicted that frontal connectivity would be most strongly impacted by treatment. Of the areas examined, we found that treatment had a significant effect only on functional connectivity between right and left dorsolateral prefrontal cortices. Implications for understanding the impact of donepezil treatment on brain functioning and behavior in patients with AD are discussed. This preliminary report suggests that fcMRI may provide a useful index of treatment outcome in diseases affecting brain connectivity. Future research should investigate these treatment-related changes in larger samples of patients and age-matched controls.
Collapse
Affiliation(s)
- Liam Zaidel
- Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX, USA
| | | | | | | | | | | | | | | | | | | |
Collapse
|
24
|
Katz WF, Garst DM, Briggs RW, Cheshkov S, Ringe W, Gopinath KS, Goyal A, Allen G. Neural bases of the foreign accent syndrome: a functional magnetic resonance imaging case study. Neurocase 2012; 18:199-211. [PMID: 22011212 DOI: 10.1080/13554794.2011.588173] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/16/2022]
Abstract
Foreign accent syndrome (FAS) is a rare disorder characterized by the emergence of a perceived foreign accent following brain damage. Despite decades of study, little is known about the neural substrates involved in this disorder. In this case study, MRI images of the brain were obtained during a speech task for an American English-speaking monolingual female who presented with FAS of unknown etiology and was thought to sound 'Swedish' or 'Eastern European'. On the basis of MR structural imaging, the patient was noted to have frontal lobe atrophy. An fMRI picture-naming task designed to broadly engage the speech motor network revealed predominantly left-hemisphere involvement, including activation of the (1) left superior temporal and medial frontal structures, (2) bilateral subcortical structures and thalamus, and (3) left cerebellum. The results suggest an instance of substantial brain reorganization for speech motor control.
Collapse
Affiliation(s)
- W F Katz
- Callier Center for Communication Disorders, The University of Texas at Dallas, 1966 Inwood Rd, Dallas, TX 75235, USA.
| | | | | | | | | | | | | | | |
Collapse
|
25
|
Murthy V, Gopinath KS. Reconstruction of groin defects following radical inguinal lymphadenectomy: an evidence based review. Indian J Surg Oncol 2012; 3:130-8. [PMID: 23730102 DOI: 10.1007/s13193-012-0145-3] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/29/2012] [Accepted: 03/13/2012] [Indexed: 10/28/2022] Open
Abstract
Inguinal lymph node involvement is an important prognostic and predictive factor in various neoplasms of the genitalia and lower limb. As part of the multimodality approach, these patients undergo surgery and adjuvant radiotherapy. Morbidity of inguinal lymphadenectomy includes lymphedema, lymphorrhea and infection; however the most common distressing complication is skin necrosis. Myocutaneous flaps have been the most popular form of primary or delayed groin reconstruction. This paper aims to critically review the different myocutaneous flaps used in groin reconstruction, discuss evidence based data on the versatility and utility of these flaps and discuss ways in which modifications maybe incorporated in treatment and radiation planning following groin reconstruction. A comprehensive search of the scientific literature was carried out using PubMed to access all publications related to groin reconstruction. The search focused specifically on current management, technique, safety and complications of these procedures. Keywords searched included "inguinal lymphadenectomy", "primary reconstruction", "musculocutaneus flap", "myocutaneous flap", "tensor fascia lata flap", "anterolateral thigh flap", "rectus abdominis flap". Low to middle income countries witness a huge burden of locally advanced genital malignancies and melanoma of the lower extremity. Higher tumor burden both at the primary site as well as the inguinal basin requires surgery as the primary modality of treatment. Groin reconstruction is required not only to prevent femoral blowouts but also for early administration of adjuvant radiation. The versatility of tensor fascia lata, anterolateral thigh, and rectus abdominis flaps is useful to cover the defect, provide radiation, eradicate pain and achieve good palliation. Assessment of aesthetic and functional outcomes of one flap over the other and the "ideal" form of reconstruction for groin defects needs additional investigation.
Collapse
Affiliation(s)
- Vijayashree Murthy
- Department of Surgical Oncology, Bangalore Institute of Oncology, Bangalore, India ; Department of Surgery, Saint Barnabas Medical Center, 94 Old Short Hills Rd., Livingston, NJ 07039 USA
| | | |
Collapse
|
26
|
Rao RM, Nagendra HR, Raghuram N, Vinay C, Chandrashekara S, Gopinath KS, Srinath BS. Influence of yoga on mood states, distress, quality of life and immune outcomes in early stage breast cancer patients undergoing surgery. Int J Yoga 2011; 1:11-20. [PMID: 21829279 PMCID: PMC3144603 DOI: 10.4103/0973-6131.36789] [Citation(s) in RCA: 55] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022] Open
Abstract
Context: Breast cancer patients awaiting surgery experience heightened distress that could affect postoperative outcomes. Aims: The aim of our study was to evaluate the effects of yoga intervention on mood states, treatment-related symptoms, quality of life and immune outcomes in breast cancer patients undergoing surgery. Settings and Design: Ninety-eight recently diagnosed stage II and III breast cancer patients were recruited for a randomized controlled trial comparing the effects of a yoga program with supportive therapy plus exercise rehabilitation on postoperative outcomes following surgery. Materials and Methods: Subjects were assessed prior to surgery and four weeks thereafter. Psychometric instruments were used to assess self-reported anxiety, depression, treatment-related distress and quality of life. Blood samples were collected for enumeration of T lymphocyte subsets (CD4 %, CD8 % and natural killer (NK) cell % counts) and serum immunoglobulins (IgG, IgA and IgM). Statistical Analysis Used: We used analysis of covariance to compare interventions postoperatively. Results: Sixty-nine patients contributed data to the current analysis (yoga n = 33, control n = 36). The results suggest a significant decrease in the state (P = 0.04) and trait (P = 0.004) of anxiety, depression (P = 0.01), symptom severity (P = 0.01), distress (P < 0.01) and improvement in quality of life (P = 0.01) in the yoga group as compared to the controls. There was also a significantly lesser decrease in CD 56% (P = 0.02) and lower levels of serum IgA (P = 0.001) in the yoga group as compared to controls following surgery. Conclusions: The results suggest possible benefits for yoga in reducing postoperative distress and preventing immune suppression following surgery.
Collapse
|
27
|
Rao RM, Nagendra HR, Raghuram N, Vinay C, Chandrashekara S, Gopinath KS, Srinath BS. Influence of yoga on postoperative outcomes and wound healing in early operable breast cancer patients undergoing surgery. Int J Yoga 2011; 1:33-41. [PMID: 21829282 PMCID: PMC3144607 DOI: 10.4103/0973-6131.36795] [Citation(s) in RCA: 43] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Abstract
CONTEXT Pre- and postoperative distress in breast cancer patients can cause complications and delay recovery from surgery. OBJECTIVE The aim of our study was to evaluate the effects of yoga intervention on postoperative outcomes and wound healing in early operable breast cancer patients undergoing surgery. METHODS Ninety-eight recently diagnosed stage II and III breast cancer patients were recruited in a randomized controlled trial comparing the effects of a yoga program with supportive therapy and exercise rehabilitation on postoperative outcomes and wound healing following surgery. Subjects were assessed at the baseline prior to surgery and four weeks later. Sociodemographic, clinical and investigative notes were ascertained in the beginning of the study. Blood samples were collected for estimation of plasma cytokines-soluble Interleukin (IL)-2 receptor (IL-2R), tumor necrosis factor (TNF)-alpha and interferon (IFN)-gamma. Postoperative outcomes such as the duration of hospital stay and drain retention, time of suture removal and postoperative complications were ascertained. We used independent samples t test and nonparametric Mann Whitney U tests to compare groups for postoperative outcomes and plasma cytokines. Regression analysis was done to determine predictors for postoperative outcomes. RESULTS Sixty-nine patients contributed data to the current analysis (yoga: n = 33, control: n = 36). The results suggest a significant decrease in the duration of hospital stay (P = 0.003), days of drain retention (P = 0.001) and days for suture removal (P = 0.03) in the yoga group as compared to the controls. There was also a significant decrease in plasma TNF alpha levels following surgery in the yoga group (P < 0.001), as compared to the controls. Regression analysis on postoperative outcomes showed that the yoga intervention affected the duration of drain retention and hospital stay as well as TNF alpha levels. CONCLUSION The results suggest possible benefits of yoga in reducing postoperative complications in breast cancer patients.
Collapse
|
28
|
Girish Rao S, Aditya TN, Gopinath KS, Anand K. Free fibula flap in the reconstruction of mandible: a report of six cases. J Maxillofac Oral Surg 2009; 8:275-8. [PMID: 23139525 DOI: 10.1007/s12663-009-0067-y] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2007] [Accepted: 04/11/2009] [Indexed: 11/26/2022] Open
Abstract
The defects secondary to surgical ablation of the mandible have far reaching consequences. Speech, respiration, mastication, deglutition and cosmesis are severely affected. Restoring these functions is a challenging task. Till the late eighties, myocutaneous flaps were the rule for mandibular reconstruction and free bone was used to restore bony continuity.In spite of the result being predictable the outcome left much to be desired. There was also a fairly regular crop of complications. Acceptable dental rehabilitation was almost non-existent. With the introduction of free flaps as a consequence of the development of the operating microscope, the field of reconstruction was revolutionized.The fibular free flap is especially suited for mandibular reconstruction. It provides adequate bone to re-establish bony continuity and also allows for the placement of osseointegrated implants.Here we present six of our cases, which underwent mandibular reconstruction with free fibula flaps and the current thoughts in literature on the reconstruction of the mandible with this technique.
Collapse
Affiliation(s)
- S Girish Rao
- Dept. of Oral and Maxillofacial Surgery, R.V. Dental College, Bangalore, India
| | | | | | | |
Collapse
|
29
|
Vadiraja HS, Raghavendra RM, Nagarathna R, Nagendra HR, Rekha M, Vanitha N, Gopinath KS, Srinath BS, Vishweshwara MS, Madhavi YS, Ajaikumar BS, Ramesh BS, Nalini R, Kumar V. Effects of a yoga program on cortisol rhythm and mood states in early breast cancer patients undergoing adjuvant radiotherapy: a randomized controlled trial. Integr Cancer Ther 2009; 8:37-46. [PMID: 19190034 DOI: 10.1177/1534735409331456] [Citation(s) in RCA: 163] [Impact Index Per Article: 10.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022] Open
Abstract
UNLABELLED Objectives. This study compares the effects of an integrated yoga program with brief supportive therapy in breast cancer outpatients undergoing adjuvant radiotherapy at a cancer center. METHODS Eighty-eight stage II and III breast cancer outpatients are randomly assigned to receive yoga (n = 44) or brief supportive therapy (n = 44) prior to radiotherapy treatment. Assessments include diurnal salivary cortisol levels 3 days before and after radiotherapy and self-ratings of anxiety, depression, and stress collected before and after 6 weeks of radiotherapy. RESULTS Analysis of covariance reveals significant decreases in anxiety (P < .001), depression (P = .002), perceived stress (P < .001), 6 a.m. salivary cortisol (P = .009), and pooled mean cortisol (P = .03) in the yoga group compared with controls. There is a significant positive correlation between morning salivary cortisol level and anxiety and depression. CONCLUSION Yoga might have a role in managing self-reported psychological distress and modulating circadian patterns of stress hormones in early breast cancer patients undergoing adjuvant radiotherapy.
Collapse
Affiliation(s)
- H S Vadiraja
- Department of Yoga Research, Swami Vivekananda Yoga Anusandhana Samsthana, Bangalore, India [corrected]
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
30
|
Ali AM, Bajaj V, Gopinath KS, Kumar A. Characterization of the human SLC22A18 gene promoter and its regulation by the transcription factor Sp1. Gene 2008; 429:37-43. [PMID: 18996451 DOI: 10.1016/j.gene.2008.10.004] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/06/2008] [Revised: 10/10/2008] [Accepted: 10/11/2008] [Indexed: 11/19/2022]
Abstract
SLC22A18, a poly-specific organic cation transporter, is paternally imprinted in humans and mice. It shows loss-of-heterozygosity in childhood and adult tumors, and gain-of-imprinting in hepatocarcinomas and breast cancers. Despite the importance of this gene, its transcriptional regulation has not been studied, and the promoter has not yet been characterized. We therefore set out to identify the potential cis-regulatory elements including the promoter of this gene. The luciferase reporter assay in human cells indicated that a region from -120 bp to +78 bp is required for the core promoter activity. No consensus TATA or CAAT boxes were found in this region, but two Sp1 binding sites were conserved in human, chimpanzee, mouse and rat. Mutational analysis of the two Sp1 sites suggested their requirement for the promoter activity. Chromatin-immunoprecipitation showed binding of Sp1 to the promoter region in vivo. Overexpression of Sp1 in Drosophila Sp1-null SL2 cells suggested that Sp1 is the transactivator of the promoter. The human core promoter was functional in mouse 3T3 and monkey COS7 cells. We found a CpG island which spanned the core promoter and exon 1. COBRA technique did not reveal promoter methylation in 10 normal oral tissues, 14 oral tumors, and two human cell lines HuH7 and A549. This study provides the first insight into the mechanism that controls expression of this imprinted tumor suppressor gene. A COBRA-based assay has been developed to look for promoter methylation in different cancers. The present data will help to understand the regulation of this gene and its role in tumorigenesis.
Collapse
Affiliation(s)
- Abdullah Mahmood Ali
- Department of Molecular Reproduction, Development and Genetics, Indian Institute of Science, Bangalore 560012, India
| | | | | | | |
Collapse
|
31
|
Rao MR, Raghuram N, Nagendra HR, Gopinath KS, Srinath BS, Diwakar RB, Patil S, Bilimagga SR, Rao N, Varambally S. Anxiolytic effects of a yoga program in early breast cancer patients undergoing conventional treatment: a randomized controlled trial. Complement Ther Med 2008; 17:1-8. [PMID: 19114222 DOI: 10.1016/j.ctim.2008.05.005] [Citation(s) in RCA: 125] [Impact Index Per Article: 7.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/14/2006] [Revised: 05/20/2008] [Accepted: 05/21/2008] [Indexed: 11/26/2022] Open
Abstract
OBJECTIVES This study compares the anxiolytic effects of a yoga program and supportive therapy in breast cancer outpatients undergoing conventional treatment at a cancer centre. METHODS Ninety-eight stage II and III breast cancer outpatients were randomly assigned to receive yoga (n=45) or brief supportive therapy (n=53) prior to their primary treatment i.e., surgery. Only those subjects who received surgery followed by adjuvant radiotherapy and six cycles of chemotherapy were chosen for analysis following intervention (yoga, n=18, control, n=20). Intervention consisted of yoga sessions lasting 60min daily while the control group was imparted supportive therapy during their hospital visits as a part of routine care. Assessments included Speilberger's State Trait Anxiety Inventory and symptom checklist. Assessments were done at baseline, after surgery, before, during, and after radiotherapy and chemotherapy. RESULTS A GLM-repeated measures ANOVA showed overall decrease in both self-reported state anxiety (p<0.001) and trait anxiety (p=0.005) in yoga group as compared to controls. There was a positive correlation between anxiety states and traits with symptom severity and distress during conventional treatment intervals. CONCLUSION The results suggest that yoga can be used for managing treatment-related symptoms and anxiety in breast cancer outpatients.
Collapse
Affiliation(s)
- M Raghavendra Rao
- Departments of CAM, Surgical Oncology, Medical Oncology and Radiation Oncology, Bangalore Institute of Oncology, Bangalore, India.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Zaremba AA, MacFarlane DL, Tseng WC, Stark AJ, Briggs RW, Gopinath KS, Cheshkov S, White KD. Optical head tracking for functional magnetic resonance imaging using structured light. J Opt Soc Am A Opt Image Sci Vis 2008; 25:1551-1557. [PMID: 18594610 DOI: 10.1364/josaa.25.001551] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
An accurate motion-tracking technique is needed to compensate for subject motion during functional magnetic resonance imaging (fMRI) procedures. Here, a novel approach to motion metrology is discussed. A structured light pattern specifically coded for digital signal processing is positioned onto a fiduciary of the patient. As the patient undergoes spatial transformations in 6 DoF (degrees of freedom), a high-resolution CCD camera captures successive images for analysis on a computing platform. A high-speed image processing algorithm is used to calculate spatial transformations in a time frame commensurate with patient movements (10-100 ms) and with a precision of at least 0.5 microm for translations and 0.1 deg for rotations.
Collapse
Affiliation(s)
- Andrei A Zaremba
- Department of Electrical Engineering, UNiversity of Texas at Dallas, Richardson, Texas 75080, USA
| | | | | | | | | | | | | | | |
Collapse
|
33
|
Chakraborty S, Mohiyuddin SMA, Gopinath KS, Kumar A. Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma. BMC Cancer 2008; 8:163. [PMID: 18538015 PMCID: PMC2430211 DOI: 10.1186/1471-2407-8-163] [Citation(s) in RCA: 81] [Impact Index Per Article: 5.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2008] [Accepted: 06/06/2008] [Indexed: 11/13/2022] Open
Abstract
Background Despite extensive research, the five-year survival rate of oral squamous cell carcinoma (OSCC) patients has not improved. Effective treatment of OSCC requires the identification of molecular targets and signaling pathways to design appropriate therapeutic strategies. Several genes from the mTOR signaling pathway are known to be dysregulated in a wide spectrum of cancers. However, not much is known about the involvement of this pathway in tumorigenesis of OSCC. We therefore investigated the role of the tumor suppressor genes, TSC1 and TSC2, and other members of this pathway in tumorigenesis of OSCC. Methods Expression of genes at the RNA and protein levels was examined by semi-quantitative RT-PCR and western blot analyses, respectively. Loss of heterozygosity was studied using matched blood and tumor DNA samples and microsatellite markers from the TSC1, TSC2 and PTEN candidate regions. The effect of promoter methylation on TSC gene expression was studied by treating cells with methyltransferase inhibitor 5-azacytidine. Methylation status of the TSC2 promoter in tissue samples was examined by combined bisulfite restriction analysis (COBRA). Results The semi-quantitative RT-PCR analysis showed downregulation of TSC1, TSC2, EIF4EBP1 and PTEN, and upregulation of PIK3C2A, AKT1, PDPK1, RHEB, FRAP1, RPS6KB1, EIF4E and RPS6 in tumors. A similar observation was made for AKT1 and RPS6KB1 expression in tumors at the protein level. Investigation of the mechanism of downregulation of TSC genes identified LOH in 36.96% and 39.13% of the tumors at the TSC1 and TSC2 loci, respectively. No mutation was found in TSC genes. A low LOH rate of 13% was observed at the PTEN locus. Treatment of an OSCC cell line with the methyltransferase inhibitor 5-azacytidine showed a significant increase in the expression of TSC genes, suggesting methylation of their promoters. However, the 5-azacytidine treatment of non-OSCC HeLa cells showed a significant increase in the expression of the TSC2 gene only. In order to confirm the results in patient tumor samples, the methylation status of the TSC2 gene promoter was examined by COBRA. The results suggested promoter hypermethylation as an important mechanism for its downregulation. No correlation was found between the presence or absence of LOH at the TSC1 and TSC2 loci in 50 primary tumors to their clinicopathological variables such as age, sex, T classification, stage, grade, histology, tobacco habits and lymph node metastasis. Conclusion Our study suggests the involvement of TSC genes and other members of the mTOR signaling pathway in the pathogenesis of OSCC. LOH and promoter methylation are two important mechanisms for downregulation of TSC genes. We suggest that known inhibitors of this pathway could be evaluated for the treatment of OSCC.
Collapse
Affiliation(s)
- Sanjukta Chakraborty
- Department of Molecular Reproduction Development and Genetics, Indian Institute of Science, Bangalore, India.
| | | | | | | |
Collapse
|
34
|
Raghavendra RM, Nagarathna R, Nagendra HR, Gopinath KS, Srinath BS, Ravi BD, Patil S, Ramesh BS, Nalini R. Effects of an integrated yoga programme on chemotherapy-induced nausea and emesis in breast cancer patients. Eur J Cancer Care (Engl) 2008; 16:462-74. [PMID: 17944760 DOI: 10.1111/j.1365-2354.2006.00739.x] [Citation(s) in RCA: 123] [Impact Index Per Article: 7.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
This study examined the effect of an integrated yoga programme on chemotherapy-related nausea and emesis in early operable breast cancer outpatients. Sixty-two subjects were randomly allocated to receive yoga (n = 28) or supportive therapy intervention (n = 34) during the course of their chemotherapy. Both groups had similar socio-demographic and medical characteristics. Intervention consisted of both supervised and home practice of yoga sessions lasting for 60 min daily, while the control group received supportive therapy and coping preparation during their hospital visits over a complete course of chemotherapy. The primary outcome measure was the Morrow Assessment of Nausea and Emesis (MANE) assessed after the fourth cycle of chemotherapy. Secondary outcomes included measures for anxiety, depression, quality of life, distressful symptoms and treatment-related toxicity assessed before and during the course of chemotherapy. Following yoga, there was a significant decrease in post-chemotherapy-induced nausea frequency (P = 0.01) and nausea intensity (P = 0.01), and intensity of anticipatory nausea (P = 0.01) and anticipatory vomiting (P = 0.05) as compared with the control group. There was a significant positive correlation between MANE scores and anxiety, depression and distressful symptoms. In conclusion, the results suggest a possible use for stress reduction interventions such as yoga in complementing conventional antiemetics to manage chemotherapy-related nausea and emesis.
Collapse
Affiliation(s)
- R M Raghavendra
- Department of Life Sciences, Swami Vivekananda Yoga Anusandhana Samsthana, Bangalore, India.
| | | | | | | | | | | | | | | | | |
Collapse
|
35
|
Gholipour A, Kehtarnavaz N, Briggs RW, Gopinath KS, Ringe W, Whittemore A, Cheshkov S, Bakhadirov K. Validation of non-rigid registration between functional and anatomical magnetic resonance brain images. IEEE Trans Biomed Eng 2008; 55:563-71. [PMID: 18269991 DOI: 10.1109/tbme.2007.912641] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
Abstract
This paper presents a set of validation procedures for nonrigid registration of functional EPI to anatomical MRI brain images. Although various registration techniques have been developed and validated for high-resolution anatomical MRI images, due to a lack of quantitative and qualitative validation procedures, the use of nonrigid registration between functional EPI and anatomical MRI images has not yet been deployed in neuroimaging studies. In this paper, the performance of a robust formulation of a nonrigid registration technique is evaluated in a quantitative manner based on simulated data and is further evaluated in a quantitative and qualitative manner based on in vivo data as compared to the commonly used rigid and affine registration techniques in the neuroimaging software packages. The nonrigid registration technique is formulated as a second-order constrained optimization problem using a free-form deformation model and mutual information similarity measure. Bound constraints, resolution level and cross-validation issues have been discussed to show the degree of accuracy and effectiveness of the nonrigid registration technique. The analyses performed reveal that the nonrigid approach provides a more accurate registration, in particular when the functional regions of interest lie in regions distorted by susceptibility artifacts.
Collapse
|
36
|
Crosson B, McGregor K, Gopinath KS, Conway TW, Benjamin M, Chang YL, Moore AB, Raymer AM, Briggs RW, Sherod MG, Wierenga CE, White KD. Functional MRI of language in aphasia: a review of the literature and the methodological challenges. Neuropsychol Rev 2007; 17:157-77. [PMID: 17525865 PMCID: PMC2659355 DOI: 10.1007/s11065-007-9024-z] [Citation(s) in RCA: 161] [Impact Index Per Article: 9.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2007] [Accepted: 03/01/2007] [Indexed: 11/26/2022]
Abstract
Animal analogue studies show that damaged adult brains reorganize to accommodate compromised functions. In the human arena, functional magnetic resonance imaging (fMRI) and other functional neuroimaging techniques have been used to study reorganization of language substrates in aphasia. The resulting controversy regarding whether the right or the left hemisphere supports language recovery and treatment progress must be reframed. A more appropriate question is when left-hemisphere mechanisms and when right-hemisphere mechanisms support recovery of language functions. Small lesions generally lead to good recoveries supported by left-hemisphere mechanisms. However, when too much language eloquent cortex is damaged, right-hemisphere structures may provide the better substrate for recovery of language. Some studies suggest that recovery is particularly supported by homologues of damaged left-hemisphere structures. Evidence also suggests that under some circumstances, activity in both the left and right hemispheres can interfere with recovery of function. Further research will be needed to address these issues. However, daunting methodological problems must be managed to maximize the yield of future fMRI research in aphasia, especially in the area of language production. In this review, we cover six challenges for imaging language functions in aphasia with fMRI, with an emphasis on language production: (1) selection of a baseline task, (2) structure of language production trials, (3) mitigation of motion-related artifacts, (4) the use of stimulus onset versus response onset in fMRI analyses, (5) use of trials with correct responses and errors in analyses, and (6) reliability and stability of fMRI images across sessions. However, this list of methodological challenges is not exhaustive. Once methodology is advanced, knowledge from conceptually driven fMRI studies can be used to develop theoretically driven, mechanism-based treatments that will result in more effective therapy and to identify the best patient candidates for specific treatments. While the promise of fMRI in the study of aphasia is great, there is much work to be done before this technique will be a useful clinical tool.
Collapse
Affiliation(s)
- Bruce Crosson
- Department of Veterans Affairs Rehabilitation Research and Development Brain Rehabilitation Research Center at the Malcom Randall VA Medical Center, Gainesville, Florida, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
37
|
Wierenga CE, Maher LM, Moore AB, White KD, McGregor K, Soltysik DA, Peck KK, Gopinath KS, Singletary F, Gonzalez-Rothi LJ, Briggs RW, Crosson B. Neural substrates of syntactic mapping treatment: an fMRI study of two cases. J Int Neuropsychol Soc 2006; 12:132-46. [PMID: 16433953 DOI: 10.1017/s135561770606019x] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/02/2004] [Revised: 10/16/2005] [Accepted: 10/17/2005] [Indexed: 11/06/2022]
Abstract
Two patients (G01, J02) with chronic nonfluent aphasia and sentence production deficits received syntactic mapping treatment to improve sentence production. The patients had dramatically different outcomes in that improved syntax production generalized to nontreatment tasks for G01, but not for JO2. To learn how treatment influenced the neural substrates for syntax production, both patients underwent pre- and posttreatment functional magnetic resonance imaging (fMRI) of sentence generation. G01 showed more robust activity posttreatment than pretreatment in Broca's area; ventral temporal activity decreased slightly from pre- to posttreatment. Comparison of J02's pretreatment and posttreatment images revealed little change, although activity was more diffuse pre- than posttreatment. Findings suggest that for G01, rehabilitation led to engagement of an area (Broca's area) used minimally during the pretreatment scan, whereas for J02, rehabilitation may have led to more efficient use of areas already involved in sentence generation during the pretreatment scan. fMRI findings are discussed in the context of sentence-production outcome and generalization.
Collapse
Affiliation(s)
- Christina E Wierenga
- Department of Veterans Affairs Rehabilitation Research and Development, Brain Rehabilitation Research Center at the Malcom Randall VA Medical Center, Gainesville, Florida, USA
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Briggs RW, Dy-Liacco I, Malcolm MP, Lee H, Peck KK, Gopinath KS, Himes NC, Soltysik DA, Browne P, Tran-Son-Tay R. A pneumatic vibrotactile stimulation device for fMRI. Magn Reson Med 2004; 51:640-3. [PMID: 15004811 DOI: 10.1002/mrm.10732] [Citation(s) in RCA: 38] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
Mapping the functional response of the somatosensory cortex is useful both for characterizing normal brain activity and for determining the functional integrity of damaged cortex compromised by stroke or other neurological insults. A variety of stimulators have been used to produce somatosensory cortex activation in functional brain imaging, including brushes and swabs operated manually, pneumatically and mechanically powered mechanical vibrators, air puffs, and vibrating ceramic piezoelectric wafers and benders. A closed-system, pneumatically driven rubber diaphragm is reported that overcomes many of the limitations of existing vibrotactile devices and produces robust sensory cortex activation in an fMRI experiment.
Collapse
Affiliation(s)
- Richard W Briggs
- Departments of Radiology, University of Florida, Gainesville, Florida, USA.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
39
|
Peck KK, Moore AB, Crosson BA, Gaiefsky M, Gopinath KS, White K, Briggs RW. Functional magnetic resonance imaging before and after aphasia therapy: shifts in hemodynamic time to peak during an overt language task. Stroke 2004; 35:554-9. [PMID: 14739418 DOI: 10.1161/01.str.0000110983.50753.9d] [Citation(s) in RCA: 72] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
BACKGROUND AND PURPOSE Comparing the temporal characteristics of hemodynamic responses in activated cortical regions of aphasic patients before and after therapy would provide insight into the relationship between improved task performance and changes in blood oxygenation level-dependent (BOLD) functional MRI (fMRI) signal. This study investigated differences in the time to peak (TTP) of hemodynamic responses in activated regions of interest (ROIs), before and after therapy, and related them to changes in task performance. METHODS Three aphasic patients and 3 controls overtly generated a single exemplar in response to a category. For the patients, TTP of hemodynamic responses in selected ROIs was compared before and after language therapy. The timing differences between auditory cues and verbal responses were compared with TTP differences between auditory and motor cortices. RESULTS The selected ROIs were significantly activated in both aphasic patients and controls during overt word generation. In the aphasic patients, both the timing difference from auditory cues to verbal responses and the TTP difference between auditory and motor cortices decreased after rehabilitation, becoming similar to the values found in controls. CONCLUSIONS Findings indicate that (1) rehabilitation increased the speed of word-finding processes; (2) TTP analysis was sensitive to this functional change and can be used to represent improvement in behavior; and (3) it is important to monitor the behavioral performance that might correlate with the temporal pattern of the hemodynamic response.
Collapse
Affiliation(s)
- Kyung K Peck
- Department of Radiology, University of Florida, Box 100374, J.H. Miller Health Center, 1600 SW Archer Rd, Gainesville, FL 32610, USA.
| | | | | | | | | | | | | |
Collapse
|
40
|
Abstract
Mastectomy is a commonly performed surgery for carcinoma of breast. During surgery, pectoral fascia is removed and pectoralis major muscle is laid bare. Sternalis is a rare muscle encountered in the subcutaneous plane. We examined the operative records of 1,152 patients who underwent modified radical mastectomies between 1990 and 2000. Patients who underwent conservative breast surgery or radical mastectomy were excluded. Among 1,152 patients who underwent modified radical mastectomy, eight were identified as having sternalis, a subcutaneously placed muscle oriented craniocaudally. The thickness of the muscle varied. The muscle was spared in all patients. Sternalis is a rare muscle in the subcutaneous plane. It should not be mistaken for a mass on mammography. During surgery it is important to be aware of this rare entity and identify the muscle early so that the dissection plane is appropriate. The depth at which internal mammary nodes are irradiated may also vary in the presence of the muscle. In addition, it should not be mistaken for recurrence on follow-up.
Collapse
Affiliation(s)
- K Harish
- Department of Surgical Oncology, M.S. Ramaiah Medical College & Hospital, 560054, Bangalore, India.
| | | |
Collapse
|
41
|
Verne GN, Himes NC, Robinson ME, Gopinath KS, Briggs RW, Crosson B, Price DD. Central representation of visceral and cutaneous hypersensitivity in the irritable bowel syndrome. Pain 2003; 103:99-110. [PMID: 12749964 DOI: 10.1016/s0304-3959(02)00416-5] [Citation(s) in RCA: 212] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/11/2022]
Abstract
We have previously shown that irritable bowel syndrome (IBS) patients have both visceral and cutaneous hyperalgesia. The neural mechanisms of these forms of hyperalgesia were further characterized by comparing cortical processing of both rectal distension (35, 55mmHg) and cutaneous heat nociceptive stimuli (foot immersion in 45 and 47 degrees C water bath) in IBS patients and in a group of healthy age/sex-matched controls. Our approach relied on functional magnetic resonance imaging neuroimaging analyses in which brain activation in age/sex-matched control subjects was subtracted from that found in IBS patients. These analyses revealed that both rectal distension and cutaneous heat stimuli evoked greater neural activity in several brain regions of IBS patients in comparison to age/sex-matched control subjects. These include those related to early stages of somatosensory processing (e.g. thalamus, somatosensory cortex) as well as those more related to cognitive and affective processing (insular, anterior cingulate, posterior cingulate, prefrontal cortex). Thus, our results support the hypothesis that hyperalgesia of IBS is manifested by increased somatosensory processing at all cortical levels. This was found to be the case not only for visceral hyperalgesia but also for cutaneous heat hyperalgesia, a likely form of secondary hyperalgesia. Furthermore, visceral and heat hyperalgesia were accompanied by increased neural activity within the same brain structures. These results support the hypothesis that visceral and cutaneous hyperalgesia in IBS patients is related to increased afferent processing in pathways ascending to the brain rather than to selectively increased activity at higher cortical levels (e.g. limbic and frontal cortical areas).
Collapse
Affiliation(s)
- G Nicholas Verne
- Research Service (151), Malcom Randall VAMC, Gainesville, FL 32608, USA.
| | | | | | | | | | | | | |
Collapse
|
42
|
|
43
|
Abstract
We have earlier shown that the estrogen-modulated riboflavin carrier protein (RCP) first isolated from the chicken egg is evolutionarily conserved in mammals and is elaborated by lactating mammary gland as demonstrated with rat mammary epithelial cells in culture and confirmed by isolation of the vitamin carrier from bovine milk. In view of several earlier reports that many milk proteins as well as other estrogen-inducible proteins are up-regulated and secreted into circulation in animal models and in women with neoplastic breast disease, we analyzed serum RCP levels in a double-blind study using a specific radioimmunoassay in pre- and post-menopausal women with clinically diagnosed breast cancer at early and advanced stages of the disease and compared these levels with those in normal age-matched control volunteers. Our data reveal that the serum RCP levels in cycling breast cancer patients are 3- to 4-fold higher (p < 0.01) than those in their normal counterparts. This difference in circulatory RCP levels between cancer patients and their age-matched normal counterparts is further magnified to 9- to 11-fold (p < 0.005) at the post-menopausal stage. In addition, there seems to be a good correlation between rising RCP levels and disease progression, since significantly higher RCP concentrations (p < 0.005) are encountered in patients with advanced metastasizing breast cancer versus those with early disease. Using specific monoclonal antibodies, RCP could be localized immunohistochemically in the cytoplasm of invading neoplastic cells of lobular and ductal carcinomas of the breast, indicating that the malignant cells are probably the source of the elevated serum RCP levels in breast cancer. These findings suggest that measurement of circulatory RCP and the immunohistochemical staining pattern of RCP in biopsy specimens could be exploited as an additional marker in diagnosis/prognosis of breast cancer in women.
Collapse
Affiliation(s)
- A A Karande
- Department of Biochemistry, Indian Institute of Science, Bangalore 560 012, India
| | | | | | | |
Collapse
|
44
|
Abstract
We have earlier shown that the estrogen-modulated riboflavin carrier protein (RCP) first isolated from the chicken egg is evolutionarily conserved in mammals and is elaborated by lactating mammary gland as demonstrated with rat mammary epithelial cells in culture and confirmed by isolation of the vitamin carrier from bovine milk. In view of several earlier reports that many milk proteins as well as other estrogen-inducible proteins are up-regulated and secreted into circulation in animal models and in women with neoplastic breast disease, we analyzed serum RCP levels in a double-blind study using a specific radioimmunoassay in pre- and post-menopausal women with clinically diagnosed breast cancer at early and advanced stages of the disease and compared these levels with those in normal age-matched control volunteers. Our data reveal that the serum RCP levels in cycling breast cancer patients are 3- to 4-fold higher (p < 0.01) than those in their normal counterparts. This difference in circulatory RCP levels between cancer patients and their age-matched normal counterparts is further magnified to 9- to 11-fold (p < 0.005) at the post-menopausal stage. In addition, there seems to be a good correlation between rising RCP levels and disease progression, since significantly higher RCP concentrations (p < 0.005) are encountered in patients with advanced metastasizing breast cancer versus those with early disease. Using specific monoclonal antibodies, RCP could be localized immunohistochemically in the cytoplasm of invading neoplastic cells of lobular and ductal carcinomas of the breast, indicating that the malignant cells are probably the source of the elevated serum RCP levels in breast cancer. These findings suggest that measurement of circulatory RCP and the immunohistochemical staining pattern of RCP in biopsy specimens could be exploited as an additional marker in diagnosis/prognosis of breast cancer in women.
Collapse
Affiliation(s)
- A A Karande
- Department of Biochemistry, Indian Institute of Science, Bangalore 560 012, India
| | | | | | | |
Collapse
|
45
|
Hazarika D, Narasimhamurthy KN, Rao CR, Gopinath KS. Fine needle aspiration cytology of Wilms' tumor. A study of 17 cases. Acta Cytol 1994; 38:355-60. [PMID: 8191824] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The cytologic features of 17 cases of Wilms' tumor are described. All three elements identifiable histologically are usually present in the fine needle aspiration smears. In our cases the blastemal component predominated, with varying degrees of epithelial and stromal differentiation, which was identifiable in the form of skeletal and smooth muscle. Early epithelial differentiation was identified as rosette-like and gland-like structures, groups of cells with peripheral palisading and spherical, tightly bound clusters of cells. More-differentiated epithelial cells were seen individually, in small, loose clusters, in sheets with a honeycomb appearance and as elongated tubules. Coarse, magenta, granular material was seen in the background of the smears in the majority of our cases. Fine needle aspiration under ultrasound guidance to accurately localize the tumor and a posterior approach to avoid peritoneal spillage are recommended. In difficult cases, a cell block of the aspirated material is a useful adjunct.
Collapse
Affiliation(s)
- D Hazarika
- Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India
| | | | | | | |
Collapse
|
46
|
Gopinath KS, Chandrashekar M, Kumar MV, Bhargava A. The scapular fasciocutaneous flap: a new flap for reconstruction of the posterior neck. Br J Plast Surg 1993; 46:508-10. [PMID: 8220859 DOI: 10.1016/0007-1226(93)90226-2] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/29/2023]
Abstract
The axial, myocutaneous and free flaps have made immediate reconstruction of head and neck defects possible. Notwithstanding this remarkable progress, defects of the posterior neck leave the reconstructive surgeon with very little choice. The scapular fasciocutaneous flap is easy to harvest, reliable and versatile, with functional and cosmetic results comparable to free flaps. We describe the anatomy and the technique of this new donor site, along with a case report.
Collapse
Affiliation(s)
- K S Gopinath
- Department of Surgery, Kidwai Memorial Institute of Oncology, Bangalore, India
| | | | | | | |
Collapse
|
47
|
Murthy SK, Prabhakaran PS, Chandrashekar M, Deshpande R, Doval DC, Gopinath KS. Neoadjuvant Cis-DDP in esophageal cancers: an experience at a regional cancer centre, India. J Surg Oncol 1990; 45:173-6. [PMID: 2232806 DOI: 10.1002/jso.2930450308] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
We are analysing the results of 80 patients who underwent surgery during 1983-84 for esophageal cancer. Forty patients who received pre-operative single agent Cis-DDP were grouped under "A" and 40 patients who went for surgery directly were grouped under "B". Twenty-two patients (55%) of Group A showed tumor necrosis. Both groups underwent resection and hand-sewn anastamosis of the esophagus. There were 10 post-operative deaths among 80 resected cases, 9 of them being from anastomatic leak. Cis-DDP has induced negligible side effects. A comparatively high survival rate during early years in patients who responded to Cis-DDP suggests that neoadjuvant chemotherapy might be of value.
Collapse
Affiliation(s)
- S K Murthy
- Department of Surgery, Kidwai Memorial Institute of Oncology, Bangalore, India
| | | | | | | | | | | |
Collapse
|
48
|
Soo KC, Shah JP, Gopinath KS, Jaques DP, Gerold FP, Strong EW. Analysis of prognostic variables and results after vertical partial laryngectomy. Am J Surg 1988; 156:264-8. [PMID: 3177747] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
A consecutive series of 197 patients who underwent conservation surgery for squamous cell carcinoma of the glottic larynx was analyzed. The majority of patients were male. One hundred forty-one had stage I disease, 44 had stage II, and 12 had stage III disease at the time of treatment. Partial laryngectomy was performed in 25 patients who had recurrent cancer after previous definitive radiotherapy and in 5 patients who had previously undergone cordectomy. There was no operative mortality and postoperative morbidity was low. Local recurrence developed in 32 patients (17 percent); cervical metastasis developed in 8 patients. The determinate survival rates at 3 and 5 years were 92 percent and 87 percent, respectively. Multivariate analysis showed soft-tissue margins and tumor differentiation as the two significant covariates in predicting survival. Positive surgical margins were also significant covariates affecting local recurrence. These data suggest that conservation surgery is an effective treatment for early vocal cord carcinoma. Adequate surgical margins are essential. Postoperative irradiation should be considered in patients with inadequate margins.
Collapse
Affiliation(s)
- K C Soo
- Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York
| | | | | | | | | | | |
Collapse
|
49
|
Soo KC, Shah JP, Gopinath KS, Gerold FP, Jaques DP, Strong EW. Analysis of prognostic variables and results after supraglottic partial laryngectomy. Am J Surg 1988; 156:301-5. [PMID: 3177756] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
Abstract
A consecutive series of 78 patients who underwent conservation surgery for squamous cell carcinoma of the supraglottic larynx is analyzed. The majority of the patients were middle-aged men who had early-stage disease, with only 18 patients in stage III and 6 in stage IV. The epiglottis was the most frequent site, followed by the aryepiglottic fold and other sites in the supraglottic larynx. There was no operative mortality and the complication rate was low. Univariate analysis showed no influence of tumor stage, tumor differentiation, or involved surgical margins on survival. Determinate survival rates of 85 percent at 3 years and 72 percent at 5 years were observed. Local recurrences took place in 12 patients, 4 of whom were salvaged by total laryngectomy; neck failure occurred in 13 patients, 7 of whom were salvaged after further treatment; and 1 of the 2 patients with distant metastasis was salvaged after further treatment. We believe that every patient with a favorable lesion of the supraglottic larynx should be considered for conservation surgery, specifically, supraglottic partial laryngectomy, adhering to the criteria mentioned. Initial surgical treatment offers excellent local control and 5 year survival. Adjuvant postoperative radiotherapy may be considered in those patients with bulky primary tumors, positive surgical margins, and histologically confirmed cervical lymph node metastases.
Collapse
Affiliation(s)
- K C Soo
- Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York
| | | | | | | | | | | |
Collapse
|
50
|
Gopinath KS, Chandrashekhar M, Kumar MV, Srikant KC. Tensor fasciae latae musculocutaneous flaps to reconstruct skin defects after radical inguinal lymphadenectomy. Br J Plast Surg 1988; 41:366-8. [PMID: 3395767 DOI: 10.1016/0007-1226(88)90075-6] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Abstract
Tensor fasciae latae flaps were used for primary reconstruction of large groin defects in 20 consecutive patients who had had radical block dissection of inguinal nodes as palliation for advanced nodal carcinoma. Excellent palliation was achieved, with lower than expected morbidity.
Collapse
Affiliation(s)
- K S Gopinath
- Kidwai Memorial Institute of Oncology, Bangalore, India
| | | | | | | |
Collapse
|